This webinar was held on November 2, 2023.
Health Management Associates (HMA) offered a 3-part series of webinars looking at the effect of proposed regulations on delivery of opioid treatment services to the population facing addiction issues. In this third and final webinar, HMA consultants highlighted opportunities for state regulators to shape policy and regulation of SUD treatment.
New federal regulations encourage significant changes to how opioid treatment is provided, with the goal of expanding access and improving patient-centered care. State regulators will need to adapt their regulatory practices and work closely with Medicaid agencies and treatment providers so the new regulations can achieve their intended goals. This webinar discussed how State Opioid Treatment Authorities (SOTAs), licensing entities, and state Medicaid agencies will need to work together to craft updated regulations, facility licensing, and reimbursement practices that advance person-centered care.
HMA experts were joined by Allegra Schorr, VP, West Midtown Medical Group and President of the Coalition of Medication-Assisted Treatment Providers and Advocates (COMPA). COMPA represents New York State’s Opioid Treatment Programs (OTPs), as well as providers offering office-based medication-assisted treatment, currently providing addiction treatment to over 43,000 New Yorkers.
- New Regulatory Requirements – Overview of state rules around opioid treatment vs the new requirements.
- How to Improve SUD Treatment Access – Specific recommendations on statutory and regulatory changes that could lead to more patient centered treatment options.
- States Leading the Way – Examples from states that are leading the way to expand access and reduce stigma.
Other webinars in this series: